Although the lack of association between these infections and MBL2 gene variants could be explained by the sample size, this could also be due to the different underlying diseases: in Mølle’s study, all patients were diagnosed with multiple myeloma while our patients had heterogeneous hematologic diseases and therefore could have had a higher risk of infection. The gene discussed is MBL2; the disease is hematologic disorder.